Literature DB >> 28064549

Mother-to-child transmission of human immunodeficiency virus (HIV) among HIV-infected pregnant women on highly active anti-retroviral therapy with premature rupture of membranes at term.

George Uchenna Eleje1,2, Emeka Stephen Edokwe3,4, Joseph Ifeanyichukwu Ikechebelu1,2,4, Chinyere Ukamaka Onubogu3,4, Ebele Francesca Ugochukwu3,4, Princeston Chukwuemeka Okam2, Adaobi Maryann Ibekwe5.   

Abstract

PURPOSE: To determine mother-to-child transmission (MTCT) rate and associated risk factors of human immune-deficiency virus (HIV) among HIV-infected pregnant women with term premature rupture of membranes (PROM) in comparison with those without PROM at term.
MATERIALS AND METHODS: All optimally managed HIV-positive pregnant women of Nnamdi Azikiwe University Teaching Hospital, on highly active anti-retroviral therapy (HAART) who had PROM at term were enrolled. Maternal HIV-1 viral load was not assessed. Follow up was for a minimum of 18 months for evidence of HIV infection.
RESULTS: Of the 121 women with PROM at term, 46 (38.0%) were HIV sero-positive, 22/46 (47.8%) of which had their babies followed up till 18 months. The mean latency period was 10.5 ± 5.3 h in PROM group. Apart from duration of PROM (OR = 0.01; 95%CI = 0.00-0.13; p < 0.001), there were no differences in risk factors seen between cases and controls (p > 0.05). Of the 22 (47.8%) babies followed-up in the PROM group and 13 in non-PROM group, none tested positive to HIV, given an MTCT rate of 0%.
CONCLUSIONS: MTCT rate was 0% following term PROM and in women without PROM. Since maternal HIV-1 viral load was not assessed, we need to be critical while interpreting the findings.

Entities:  

Keywords:  HAART; MTCT of HIV; PROM; rupture of membranes

Mesh:

Substances:

Year:  2017        PMID: 28064549     DOI: 10.1080/14767058.2017.1279600

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  2 in total

Review 1.  Mother-to-child transmission of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among pregnant women with single, dual or triplex infections of human immunodeficiency virus, hepatitis B virus and hepatitis C virus in Nigeria: A systematic review and meta-analysis.

Authors:  George Uchenna Eleje; Chinyere Ukamaka Onubogu; Preye Owen Fiebai; Ikechukwu Innocent Mbachu; Godwin Otuodichinma Akaba; Olabisi Morebise Loto; Hadiza Abdullahi Usman; Ayyuba Rabiu; Moriam Taiwo Chibuzor; Rebecca Chinyelu Chukwuanukwu; Ngozi Nneka Joe-Ikechebelu; Chike Henry Nwankwo; Stephen Okoroafor Kalu; Chukwuanugo Nkemakonam Ogbuagu; Shirley Nneka Chukwurah; Chinwe Elizabeth Uzochukwu; Ijeoma Chioma Oppah; Aishat Ahmed; Richard Obinwanne Egeonu; Chiamaka Henrietta Jibuaku; Samuel Oluwagbenga Inuyomi; Bukola Abimbola Adesoji; Ubong Inyang Anyang; Uchenna Chukwunonso Ogwaluonye; Ekene Agatha Emeka; Odion Emmanuel Igue; Ogbonna Dennis Okoro; Prince Ogbonnia Aja; Chiamaka Perpetua Chidozie; Hadiza Sani Ibrahim; Fatima Ele Aliyu; Aisha Ismaila Numan; Solace Amechi Omoruyi; Osita Samuel Umeononihu; Chukwuemeka Chukwubuikem Okoro; Ifeanyi Kingsley Nwaeju; Arinze Anthony Onwuegbuna; Eric Okechukwu Umeh; Sussan Ifeyinwa Nweje; Lydia Ijeoma Eleje; Ifeoma Clara Ajuba; David Chibuike Ikwuka; Emeka Philip Igbodike; Chisom God'swill Chigbo; Uzoamaka Rufina Ebubedike; Chigozie Geoffrey Okafor; Nnaedozie Paul Obiegbu; Ibrahim Adamu Yakasai; Oliver Chukwujekwu Ezechi; Joseph Ifeanyichukwu Ikechebelu
Journal:  SAGE Open Med       Date:  2022-04-28

2.  Prevalence, seroconversion and mother-to-child transmission of dual and triplex infections of HIV, hepatitis B and C viruses among pregnant women in Nigeria: study protocol.

Authors:  George Uchenna Eleje; Ikechukwu Innocent Mbachu; Uchenna Chukwunonso Ogwaluonye; Stephen Okoroafor Kalu; Chinyere Ukamaka Onubogu; Sussan Ifeyinwa Nweje; Chinwe Elizabeth Uzochukwu; Chike Henry Nwankwo; Preye Owen Fiebai; Olabisi Morebise Loto; Godwin Otuodichinma Akaba; Hadiza Abdullahi Usman; Ayyuba Rabiu; Richard Obinwanne Egeonu; Odion Emmanuel Igue; Bukola Abimbola Adesoji; Chiamaka Henrietta Jibuaku; Prince Ogbonnia Aja; Chiamaka Perpetua Chidozie; Hadiza Sani Ibrahim; Fatima Ele Aliyu; Aisha Ismaila Numan; Ogbonna Dennis Okoro; Solace Amechi Omoruyi; Ijeoma Chioma Oppah; Ubong Inyang Anyang; Aishat Ahmed; Shirley Nneka Chukwurah; Osita Samuel Umeononihu; Rebecca Chinyelu Chukwuanukwu; Eric Okechukwu Umeh; Ekene Agatha Emeka; Chukwuanugo Nkemakonam Ogbuagu; Ibrahim Adamu Yakasai; Oliver Chukwujekwu Ezechi; Joseph Ifeanyichukwu Ikechebelu
Journal:  Reprod Health       Date:  2020-09-25       Impact factor: 3.223

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.